IBDEI0F5 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6943,0)
 ;;=787.20^^31^415^58
 ;;^UTILITY(U,$J,358.3,6943,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6943,1,4,0)
 ;;=4^787.20
 ;;^UTILITY(U,$J,358.3,6943,1,5,0)
 ;;=5^Dysphagia
 ;;^UTILITY(U,$J,358.3,6943,2)
 ;;=^335307
 ;;^UTILITY(U,$J,358.3,6944,0)
 ;;=789.59^^31^415^28
 ;;^UTILITY(U,$J,358.3,6944,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6944,1,4,0)
 ;;=4^789.59
 ;;^UTILITY(U,$J,358.3,6944,1,5,0)
 ;;=5^Ascites
 ;;^UTILITY(U,$J,358.3,6944,2)
 ;;=^335282
 ;;^UTILITY(U,$J,358.3,6945,0)
 ;;=790.6^^31^415^13
 ;;^UTILITY(U,$J,358.3,6945,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6945,1,4,0)
 ;;=4^790.6
 ;;^UTILITY(U,$J,358.3,6945,1,5,0)
 ;;=5^Abnormal LFT's
 ;;^UTILITY(U,$J,358.3,6945,2)
 ;;=^87228
 ;;^UTILITY(U,$J,358.3,6946,0)
 ;;=790.29^^31^415^83
 ;;^UTILITY(U,$J,358.3,6946,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6946,1,4,0)
 ;;=4^790.29
 ;;^UTILITY(U,$J,358.3,6946,1,5,0)
 ;;=5^Hyperglycemia (NOT DM)
 ;;^UTILITY(U,$J,358.3,6946,2)
 ;;=^329955
 ;;^UTILITY(U,$J,358.3,6947,0)
 ;;=780.60^^31^415^70
 ;;^UTILITY(U,$J,358.3,6947,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6947,1,4,0)
 ;;=4^780.60
 ;;^UTILITY(U,$J,358.3,6947,1,5,0)
 ;;=5^Fever
 ;;^UTILITY(U,$J,358.3,6947,2)
 ;;=^336764
 ;;^UTILITY(U,$J,358.3,6948,0)
 ;;=784.59^^31^415^138
 ;;^UTILITY(U,$J,358.3,6948,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6948,1,4,0)
 ;;=4^784.59
 ;;^UTILITY(U,$J,358.3,6948,1,5,0)
 ;;=5^Speech Disturbance NEC
 ;;^UTILITY(U,$J,358.3,6948,2)
 ;;=^338287
 ;;^UTILITY(U,$J,358.3,6949,0)
 ;;=799.21^^31^415^112
 ;;^UTILITY(U,$J,358.3,6949,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6949,1,4,0)
 ;;=4^799.21
 ;;^UTILITY(U,$J,358.3,6949,1,5,0)
 ;;=5^Nervousness
 ;;^UTILITY(U,$J,358.3,6949,2)
 ;;=^338291
 ;;^UTILITY(U,$J,358.3,6950,0)
 ;;=786.30^^31^415^78
 ;;^UTILITY(U,$J,358.3,6950,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6950,1,4,0)
 ;;=4^786.30
 ;;^UTILITY(U,$J,358.3,6950,1,5,0)
 ;;=5^Hemoptysis
 ;;^UTILITY(U,$J,358.3,6950,2)
 ;;=^339669
 ;;^UTILITY(U,$J,358.3,6951,0)
 ;;=787.60^^31^415^89
 ;;^UTILITY(U,$J,358.3,6951,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6951,1,4,0)
 ;;=4^787.60
 ;;^UTILITY(U,$J,358.3,6951,1,5,0)
 ;;=5^Incontinence of Feces
 ;;^UTILITY(U,$J,358.3,6951,2)
 ;;=^339670
 ;;^UTILITY(U,$J,358.3,6952,0)
 ;;=780.99^^31^415^153
 ;;^UTILITY(U,$J,358.3,6952,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6952,1,4,0)
 ;;=4^780.99
 ;;^UTILITY(U,$J,358.3,6952,1,5,0)
 ;;=5^Vague/General Symptoms
 ;;^UTILITY(U,$J,358.3,6952,2)
 ;;=^328568
 ;;^UTILITY(U,$J,358.3,6953,0)
 ;;=783.21^^31^415^15
 ;;^UTILITY(U,$J,358.3,6953,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6953,1,4,0)
 ;;=4^783.21
 ;;^UTILITY(U,$J,358.3,6953,1,5,0)
 ;;=5^Abnormal Weight Loss
 ;;^UTILITY(U,$J,358.3,6953,2)
 ;;=^322005
 ;;^UTILITY(U,$J,358.3,6954,0)
 ;;=277.85^^31^415^53
 ;;^UTILITY(U,$J,358.3,6954,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6954,1,4,0)
 ;;=4^277.85
 ;;^UTILITY(U,$J,358.3,6954,1,5,0)
 ;;=5^Disorder Acid Oxidation
 ;;^UTILITY(U,$J,358.3,6954,2)
 ;;=^331443
 ;;^UTILITY(U,$J,358.3,6955,0)
 ;;=277.86^^31^415^125
 ;;^UTILITY(U,$J,358.3,6955,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6955,1,4,0)
 ;;=4^277.86
 ;;^UTILITY(U,$J,358.3,6955,1,5,0)
 ;;=5^Peroxisomal Disorder
 ;;^UTILITY(U,$J,358.3,6955,2)
 ;;=^331444
 ;;^UTILITY(U,$J,358.3,6956,0)
 ;;=277.87^^31^415^52
 ;;^UTILITY(U,$J,358.3,6956,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6956,1,4,0)
 ;;=4^277.87
 ;;^UTILITY(U,$J,358.3,6956,1,5,0)
 ;;=5^Dis Mitochondrial Metab
 ;;^UTILITY(U,$J,358.3,6956,2)
 ;;=^331445
 ;;^UTILITY(U,$J,358.3,6957,0)
 ;;=273.4^^31^415^21
 ;;
 ;;$END ROU IBDEI0F5
